-

10:36:05 PM

BHC Stock News

BHC - Bausch Health Companies Inc

12/01/22 8:00 AM

NYSE : BHC

Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider

Launching in December for Constipation Awareness Month, Initiatives Include Partnerships with Well-Known Lifestyle and Health Care Practitioner Influencers Campaign Coincides with Salix's Continued Support of Advocacy Groups Building Innovative Patient Education Programs and Advancing Disease State

RHEA-AI

very positive

11/29/22 5:50 PM

NYSE : BHC

Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") has designated 1261229 B.C. Ltd., the entity that directly or indirectly holds 88.7% of the issued and outstanding shares of Bausch + Lomb Corporation ("Bausch + Lomb"),

RHEA-AI

neutral

11/15/22 6:05 PM

NYSE : BHLB, KBRA, BHC

KBRA Releases Third-Quarter 2022 U.S. Bank Compendium and 2023 Sector Outlook

Bank Compendium and 2023 Sector Outlook, providing the latest view of the U.S. banking industry, including KBRA’ s sector outlook, and analysis of 3 Q22 results for U.S. banks with KBRA long-term ratings. Despite an uncertain macro environment, we recognize banks as better positioned to withstand stressed conditions versus previous cycles, with stronger...

RHEA-AI

neutral

11/04/22 8:00 AM

NYSE : BHC

Salix Will Present Rifaximin Data at AASLD's The Liver Meeting(R) 2022

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals ("Salix"), today announced one de novo abstract that is being presented at The Liver Meeting® 2022, organized by the American

RHEA-AI

neutral

11/03/22 7:00 AM

NYSE : BHC

Bausch Health Announces Third-Quarter 2022 Results

RHEA-AI

neutral

11/01/22 8:00 AM

NYSE : BHC

conferences

Ortho Dermatologics to Present New Data at the 2022 Innovations in Dermatology Conference

- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced the presentation of nine posters during the

RHEA-AI

neutral

10/31/22 8:00 AM

NYSE : BHC

Ortho Dermatologics Announces U.S. Launch of the Podiatry Board Review Challenge

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its dermatology business, Ortho

RHEA-AI

negative

10/24/22 8:00 AM

NYSE : BHC

Salix Will Present XIFAXAN(R) (Rifaximin), TRULANCE(R) (Plecanatide) and RELISTOR(R) (Methylnaltrexone Bromide) Data at The American College of Gastroenterology(R) 2022 Annual Scientific Meeting

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals ("Salix"), today announced four posters and one abstract featuring data for XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and

RHEA-AI

neutral

10/20/22 8:00 AM

NYSE : BHC

conferences

Ortho Dermatologics To Present New Data at the 2022 Fall Clinical Dermatology Conference

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced the presentation of eleven posters

RHEA-AI

negative

10/13/22 8:00 AM

NYSE : BHC

Bausch Health to Announce Third Quarter 2022 Results on Nov. 3

Bausch Health Companies Inc. (NYSE/TSX:BHC) ("Bausch Health") will release its third quarter financial results on Thursday, Nov. 3, 2022. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EDT to discuss the results and provide a

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next

BHC Data

IndustryPharmaceutical Preparation Manufacturing
Websitewww.bauschhealth.com
Security nameBausch Health Companies Inc
Issue typecs
SectorManufacturing
Sic code2834
Employees21600
Tags
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Address2150 Saint-Elzear Blvd W
StateQuebec
CityLaval
ZipH7L 4A8
CountryCanada
Phone15149406743

About Bausch Health Companies Inc

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.